Five sites across the country are ready for the third and final phase of human trials of the Oxford-AstraZeneca COVID-19 vaccine, Department of Biotechnology (DBT) Secretary Renu Swarup said on Monday.

This is an essential step because it is necessary to have data within the country before the vaccine is administered to Indians, Swarup told PTI.